ShareValue scores for 300006.SHE: Valuation 44, Quality 29, Growth 47, Health 50.
300006.SHESZSE
Chongqing Lummy Pharmaceutical
CN¥4.73
(+5.35%)
300006.SHESZSE
Chongqing Lummy Pharmaceutical
CN¥4.73(+5.35%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 17%
Rating
Trap Risk
Return
5% to 17%
Valuation
44
Fair Value
Price vs Value
Quality
29
Weak
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
24
Bearish
Price Trend
Company Details
About
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China.
Market Cap$4.99B
P/E RatioN/A
Dividend YieldNone
Sector Rank#2317
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026